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spike-timing-dependent potentiation in the
striatum
Hao Xu1,2, Sylvie Perez1,2, Amandine Cornil3, Bérangère Detraux3, Ilya Prokin4,5, Yihui Cui1,2, Bertrand Degos1,2,
Hugues Berry 4,5, Alban de Kerchove d’Exaerde 3,6 & Laurent Venance 1,2
Dopamine modulates striatal synaptic plasticity, a key substrate for action selection and
procedural learning. Thus, characterizing the repertoire of activity-dependent plasticity in
striatum and its dependence on dopamine is of crucial importance. We recently unraveled a
striatal spike-timing-dependent long-term potentiation (tLTP) mediated by endocannabinoids
(eCBs) and induced with few spikes (~5–15). Whether this eCB-tLTP interacts with the
dopaminergic system remains to be investigated. Here, we report that eCB-tLTP is impaired
in a rodent model of Parkinson’s disease and rescued by L-DOPA. Dopamine controls eCB-
tLTP via dopamine type-2 receptors (D2R) located presynaptically in cortical terminals.
Dopamine–endocannabinoid interactions via D2R are required for the emergence of tLTP
in response to few coincident pre- and post-synaptic spikes and control eCB-plasticity by
modulating the long-term potentiation (LTP)/depression (LTD) thresholds. While usually
considered as a depressing synaptic function, our results show that eCBs in the presence of
dopamine constitute a versatile system underlying bidirectional plasticity implicated in basal
ganglia pathophysiology.
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Endocannabinoids (eCBs) have emerged as a major signalingsystem in learning and memory because of their powerfulinfluence on synaptic plasticity, mainly as depressing
synaptic function1,2. There exists a growing body of evidence that
eCBs are also associated with synaptic potentiation2. Indeed,
eCBs promote long-term potentiation (LTP) at mixed (chemical
and electrical) synapses of the goldfish Mauthner cell via inter-
mediary dopaminergic neurons3 or at hippocampal CA1 synapses
via a GABAA receptor-mediated mechanism4–6, facilitation of
hippocampal LTP via eCB-induced presynaptic depression of
GABAergic transmission7, and heterosynaptic short-term
potentiation via the astrocytic network8. Recently, a direct role
of eCBs has been found in promoting LTP in the dentate
gyrus9,10, the somatosensory cortex11, and the dorsolateral
striatum12,13.
The striatum is a strategic gate extracting pertinent cortical
information and a major site of memory formation. Indeed,
synaptic plasticity at corticostriatal synapses14–19, changes of
striatal neuronal activity14,20, and corticostriatal coherence21 have
been associated with the acquisition or extinction in the beha-
vioral repertoire. The striatum receives a dense innervation from
midbrain dopaminergic neurons, one of the key players of basal
ganglia function in action selection and associative learning22. In
particular, dopamine plays a crucial role in goal-directed behavior
and reinforcement learning, which is dramatically highlighted in
neuronal disorders affecting corticostriatal information proces-
sing, such as Parkinson’s disease23.
Dopamine and synaptic plasticity signaling pathways interac-
tion is required for the induction of the main form of striatal
plasticity: the endocannabinoid-mediated long-term depression
(eCB-LTD)24. At corticostriatal synapses, eCB-LTD has con-
sistently been observed using various cell-conditioning paradigms
(high- and low-frequency stimulation, theta-burst protocols, or
spike-timing-dependent plasticity)24–26. The striatum receives a
wide range of patterns of cortical activities from isolated trains of
few spikes to prolonged bursting events. While plasticity under
prolonged activation is well elucidated, its expression in response
to few spikes remains less documented. To this end, we chose
spike-timing-dependent plasticity (STDP) as a synaptic Hebbian
learning paradigm27. Indeed, STDP (tLTP and tLTD) depends on
the relative timing between pre- and postsynaptic spikes, and
relies on much fewer events (around 100 paired stimulations)
than the high- or low-frequency stimulation protocols (hundreds
of stimulations). In the striatum, bidirectional STDP with
NMDAR-mediated tLTP and eCB-mediated tLTD, has been
reported with 100–150 paired stimulations26,28–32. Using STDP,
we recently reported a new form of plasticity in the dorsolateral
striatum: a striatal spike-timing-dependent potentiation (tLTP)
induced by few coincident pre- and post-synaptic spikes (~5–15),
mediated by eCBs (eCB-tLTP) through a signaling pathway that
relies on the activation of type-1 cannabinoid receptor (CB1R)
and transient receptor potential vanilloid type-1 (TRPV1) and on
eCB dynamics12,13. Corticostriatal eCB-tLTP relies on post-
synaptic synthesis and release of eCBs, which mainly activate
presynaptic CB1R, and displays a presynaptic locus of plasticity
maintenance. We previously showed that the bidirectionality of
eCB-dependent STDP in striatum is controlled by eCB-levels:
prolonged and moderate release of eCBs leads to eCB-tLTD,
whereas brief and large eCB transients produce eCB-tLTP13.
Moreover, in striatum, eCB-STDP is controlled by the protein
kinase A (PKA) and calcineurin activity balance, such as eCB-
tLTD requires active calcineurin whereas eCB-tLTP necessitates
the activity of presynaptic PKA12,13.
Thus, eCBs not only promote depression but also potentiation,
i.e., they act as a bidirectional system, depending on the regime of
activity pattern on either side of the synapse. The interactions
between the dopaminergic system and eCB-LTD have thoroughly
been studied and a solid experimental support exists for the
efficient modulation of eCB-LTD by dopamine24. However,
whether and how eCB-tLTP may be modulated by dopamine and
consequently be affected in Parkinson’s disease remains
unknown. Thus, considering the crucial role of dopamine in
striatal physiology and pathophysiology and in particular in
synaptic plasticity22–24,33,34, we question here the implication of
dopamine in the expression of eCB-tLTP. We observe that eCB-
tLTP is impaired in a rodent model of Parkinson’s disease and is
rescued by L-DOPA treatment. We find that opto-inhibition of
dopaminergic neurons prevent eCB-tLTP and that dopamine
type-2 receptors (D2R) on cortical terminals are required for eCB-
tLTP expression. We provide a biologically plausible mathema-
tical model for the dynamics of the implicated signaling path-
ways. Combining our experimental results and modeling, we
show that dopamine controls not only the induction but also the
polarity via presynaptic D2R (tLTP vs tLTD) of eCB-plasticity by
modulating the effective eCB thresholds.
Results
Distinct STDP activity patterns induced eCB-tLTP and -tLTD.
STDP is a synaptic Hebbian learning rule in which synaptic
weight changes depend on the activity on both sides of the
synapse27. Corticostriatal synapses exhibit a bidirectional eCB-
dependent STDP in which eCB-tLTD12,28–32 or eCB-tLTP12,13
are induced depending on the spike timing (ΔtSTDP) and on the
number of pairings (Npairings). In the dorsolateral striatum, we
recently reported that a low number of pairings (Npairings= 5–15)
induces an eCB-tLTP, dependent on the activation of CB1R and
TRPV112,13. It is well documented that eCB-LTD (mainly
induced with high- or low-frequency stimulation protocols) is
controlled by dopamine levels24. However, the dopaminergic
control of eCB-tLTP remains undocumented. Here, to examine
the dopamine dependence of eCB-tLTP, we carried out whole-cell
recordings from medium-sized spiny neurons (MSNs) of the
dorsolateral striatum (Fig. 1a): after measuring baseline EPSCs for
10 min, recordings were switched to current-clamp to pair a
single EPSP induced by presynaptic cortical stimulation with a
single postsynaptic spike induced by a brief depolarization of the
MSN (Fig. 1a). The STDP protocol consisted in pairing of pre-
and postsynaptic stimulations separated by a certain fixed timing
interval (ΔtSTDP) and repeated 10 or 100 times at 1 Hz. ΔtSTDP < 0
when the post-synaptic stimulation occurs before the paired pre-
synaptic one (post-pre pairings) (Fig. 1a), whereas ΔtSTDP > 0
when the pre-synaptic stimulation occurs before the post-
synaptic one (pre-post pairings) (Fig. S1a).
We observed that 10 post-pre and 100 pre-post pairings
induced a bidirectional anti-Hebbian eCB-STDP with eCB-tLTP
induced by 10 post-pre pairings (Fig. 1b, c) and eCB-tLTD by 100
pre-post pairings (Supplementary Fig. 1). GABA operates as a
Hebbian/anti-Hebbian switch at corticostriatal synapses32,35
because corticostriatal STDP polarity depends on the presence
(ex vivo Hebbian STDP28,29) or the absence of GABAA receptor
antagonists (ex vivo anti-Hebbian STDP12,13,30,31, as well as in
this study; in vivo anti-Hebbian STDP36). We thus recorded
STDP in the absence of GABAAR antagonist to preserve the local
striatal microcircuits and the anti-Hebbian polarity as observed
in vivo36. Figure 1b and Supplementary Figure 1b show examples
of tLTP and tLTD induced by 10 post-pre and 100 pre-post
pairings, respectively. To summarize, 10 post-pre STDP pairings
(−30 < ΔtSTDP < 0 ms) induced tLTP (mean value of the EPSC
amplitude recorded 50 min after STDP protocol: 158 ± 11%, p=
0.0006, n= 9), which was prevented by AM251 (3 μM), a CB1R
specific inhibitor (80 ± 14%, p= 0.2223, n= 5) or with AMG9810
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(1 μM), a TRPV1-specific inhibitor (98 ± 7%, p= 0.7723, n= 5)
(Fig. 1c) as recently reported12,13. 100 pre-post pairings (0 <
ΔtSTDP <+30ms) induced tLTD (71 ± 10%, p= 0.0253, n= 7),
which was prevented by AM251 (103 ± 7%, p= 0.7500, n= 7) or
with AMG9810 (99 ± 10%, p= 0.9197, n= 5) (Supplementary
Fig. 1c–d) confirming previous reports13,28–32. Thus, we confirm
that eCB system encodes for bidirectional striatal plasticity
depending on the number and order of pairings.
CB1R being located at the presynaptic terminals of the
corticostriatal pathway1,24, the locus of eCB-tLTP maintenance
would likely be presynaptic. We applied presynaptic paired-pulses
(50 ms interpulse interval) before and 45 min after STDP
pairings, and observed a EPSC paired-pulse facilitation12,13. We
observed a decrease of the paired-pulse ratio (paired-pulse
ratioplasticity/baseline= 0.855 ± 0.04, p= 0.0032, n= 16) 45 min
after the 10 post-pre pairings (Fig. 1d), which indicates a
presynaptic locus of eCB-tLTP. The mean variance analysis of
EPSCs gave a CV−2 value of 3.55 ± 0.60 (p < 0.0001, n= 21),
which also indicates a presynaptic locus for eCB-tLTP (Fig. 1e).
We investigated the impact of GABAergic networks on eCB-
tLTP, which could arise from a decrease of GABA release, as
reported for hippocampal eCB-LTP4,7. When ionotropic
GABAergic transmission was blocked with picrotoxin (50 μM),
tLTP was observed for 10 pre-post pairings (142 ± 18%, p=
0.0008, n= 7), whereas no detectable plasticity was found for 10
post-pre pairings (99 ± 19%, p= 0.8909, n= 8) (Fig. 1f). tLTP
magnitudes observed in control and picrotoxin conditions were
not significantly different (p= 0.4575). Therefore, GABAergic
circuits do not control the expression of eCB-tLTP but control its
timing dependence, in agreement with the GABA effects reported
for 100 pairings NMDA-tLTP and eCB-LTD32,35.
The subthreshold postsynaptic depolarization itself is a key
factor in the induction of striatal plasticity37. We tested whether
postsynaptic spikes were required for eCB-tLTP induction. To
this aim, we delivered intracellularly in the postsynaptic recorded
MSN via the patch pipette the QX-314 (10 μM), a Na+ channel
inhibitor, and observed tLTP with 10 post-pre pairings (158 ±
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Fig. 1 eCB-tLTP is induced by low number of pairings. a Characteristic voltage responses of a MSN to a series of 500ms current pulses from −150 to
+180 pA with current steps increasing by 30 pA (black traces) and to +60 pA above spike threshold (grey trace). STDP protocol: a spike-evoked in one
MSN was paired with a cortical stimulation repeated 10 times at 1 Hz. ΔtSTDP indicates the temporal time shift between pre- and postsynaptic stimulations.
b, c 10 post-pre pairings induced tLTP CB1R- and TRPV1-activation dependent. b Example of tLTP induced by 10 post-pre pairings (ΔtSTDP=−13 ms). Top,
EPSC strength before and after 10 pairings (124 ± 4 pA and 203 ± 3 pA, p < 0.0001). Bottom, time courses of input resistance (Ri) (before, 99 ± 1MΩ; after,
105 ± 1MΩ; change of 6%), access resistance (Raccess) (before, 30 ± 1 kΩ; after, 29 ± 1 kΩ; change of 3%) and injected current (Iinj) (before, 24 ± 0.3 pA;
after, 23 ± 0.2 pA). c Summary of STDP experiments showing that eCB-tLTP induced with 10 post-pre pairings (n= 9, 9 cells out of 9 resulted in tLTP) is
prevented by a specific CB1R or TRPV1 inhibitor, AM251 (3 µm, n= 5, 1/5 showed tLTP) and AMG9810 (1 µM, n= 5, 0/5 showed tLTP), respectively.
d Summary bar graphs (n= 16 MSNs) of paired-pulse cortical stimulations (50ms interstimulus interval) illustrate a decrease of facilitation after 10 post-
pre pairings. This indicates a presynaptic locus of the eCB-tLTP. e Mean variance analysis (CV−2plasticity/baseline, n= 21) during baseline and 45min after
STDP pairings indicates a presynaptic locus of the eCB-tLTP. f With inhibition of ionotropic GABAergic transmission (picrotoxin 50 μM), tLTP was
observed with pre-post (n= 7, 6/7 showed tLTP) but not with post-pre (n= 8, 1/8 showed tLTP) pairings. GABA controls the time dependence but not the
magnitude of eCB-tLTP. g Intracellular application of a Na+ channel blocker, QX-314 (1 µm, n= 5, 5/5 showed tLTP), did not prevent 10 post-pre pairings
LTP. Representative traces are the average of 15 EPSCs during baseline (black traces) and 45min after STDP protocol (grey traces). Vertical grey dashed
line indicates the STDP protocol. Error bars represent sem. *p < 0.05; **p < 0.01; ***p < 0.001; ns: not significant by t-test, two-tailed (b), one sample t-test
(c, f, g) or Wilcoxon Signed rank test (c, d)
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depolarizations (30 ms duration) appeared sufficient to induce
striatal eCB-tLTP.
eCB-tLTP is impaired in Parkinson’s and rescued by L-DOPA.
Whereas NMDAR-LTP and eCB-LTD striatal synaptic plasticity
are dependent on dopamine and therefore are impacted in Par-
kinson’s disease23,24,34, it is not known whether eCB-tLTP is
affected in Parkinson’s disease. To address this question, we used
a rat model of Parkinson’s disease in which dopaminergic
transmission is impaired. We performed unilateral lesion of the
substantia nigra pars compacta (SNc) with 6-hydroxy-dopamine
(6-OHDA), a neurotoxic synthetic organic compound which
leads, when associated with desipramine, to the selective degen-
eration of dopaminergic neurons (Fig. 2a, b). We observed a
massive degeneration of nigral dopaminergic neurons and of their
striatal terminals as shown by the dramatic decrease of striatal
tyrosine hydroxylase (TH) staining by 64 ± 5% (p < 0.0001, n= 7)
2 weeks after the 6-OHDA lesions at P50 (Fig. 2b). We also used
sham-operated animals with saline injection for comparison
with the 6-OHDA-lesioned rats (Fig. 2a, b). We first verified that
tLTP was induced with 10 post-pre pairings in adult control rats
(i.e., without any surgery and recorded at similar age than the
sham-operated and 6-OHDA-lesioned rats, P(60–65)) (164 ± 16%,
p= 0.0034, n= 10; Supplementary Fig. 2a) and in sham-operated
rats (147 ± 7%, p= 0.0002, n= 9; Fig. 2c). The tLTP induced in
adult control animals and in sham-operated rats were not dif-
ferent (p= 0.7019). In contrast, in the 6-OHDA-lesioned animals,
10 post-pre pairings failed to induce any plasticity (94 ± 5%,
p= 0.2741, n= 9; Fig. 2c) thus showing that the degeneration
of dopaminergic neurons is deleterious for the induction of
eCB-tLTP.
We next tested whether treatment with L-3,4-dihydroxypheny-
lalanine (L-DOPA; Fig. 2a), a mainstay for symptomatic treatment
of Parkinson’s disease, could rescue eCB-tLTP in 6-OHDA-
lesioned rats. In slices obtained from 6-OHDA-lesioned animals
treated with L-DOPA, 10 post-pre pairings caused tLTP (171 ±
19%, p= 0.0096, n= 7; Fig. 2d); this tLTP was not different from
the tLTP obtained in sham-operated rats (p= 0.3481). tLTP was
also observed in the sham-operated animals L-DOPA-treated
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Fig. 2 eCB-tLTP is impaired in a rat model of Parkinson’s and rescued by L-DOPA. a Protocols of the 6-OHDA lesion (or sham) in P35 rats followed 2 weeks
after by chronic L-DOPA treatment (or saline) for 10 days. b Unilateral 6-OHDA injection in SNc led to degeneration of dopaminergic nigral neurons and a
loss of their striatal afferences as illustrating by TH immunostaining in horizontal brain slices. Note that sham-operated rats display equivalent TH staining
in both striata. Scale bars: 1 mm and 200 µm. Right panel: summary bar graph of TH staining quantification. c 10 post-pre pairings induced eCB-tLTP in
sham-operated rats (n= 9, 9/9 cells showed tLTP) while no plasticity was observed in 6-OHDA-lesioned rats (n= 9, 1/9 cells showed tLTP). d Chronic
L-DOPA treatment consisting in twice daily injection of L-DOPA (10mg/kg) for 10 days, 2 weeks after 6-OHDA lesion allowed to recover tLTP (n= 7, 6/7
cells showed tLTP) induced with 10 post-pre pairings. This tLTP was CB1R-mediated since prevented by AM251 (3 µm, n= 6, 0/6 cells showed tLTP) in
6-OHDA-lesioned rats treated with L-DOPA. Representative traces are the average of 15 EPSCs during baseline (black traces) and 45min after STDP
protocol (grey traces). Vertical grey dashed line indicates the STDP protocol. Error bars represent sem. **p < 0.01; ***p < 0.001; ns: not significant by one
sample t-test (c, d) or Wilcoxon Signed rank test (b)
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tLTP was not different from the one obtained in sham-operated
rats (p= 0.4038) or in 6-OHDA-lesioned animals treated with
L-DOPA (p= 0.7791). In 6-OHDA-lesioned animals L-DOPA-
treated, tLTP induced with 10 post-pre pairings was CB1R-
mediated since prevented by AM251 (81 ± 6%, p= 0.0244, n= 6;
Fig. 2d). Therefore, eCB-tLTP was impaired in a rodent model of
Parkinson’s disease and was rescued by L-DOPA treatment.
Dopamine is required for eCB-tLTP induction. Cortical sti-
mulation enhances dopamine release in the dorsal striatum38–40.
We investigated if dopamine was required during the few pairings
of the induction phase of eCB-tLTP. To this intent, we opto-
inhibited dopaminergic neurons during the few pairings
responsible for eCB-tLTP in DAT-Cre+/−::Arch3-GFP+/− mice.
We confirmed that Arch3-GFP expression was restricted to
dopaminergic neurons and terminals in the striatum with TH and
GFP immunostainings (n= 10) in SNc and dorsal striatum
(Fig. 3a). We ensured the efficiency of the opto-inhibition by cell-
attached recordings of the spontaneous spiking activity of dopa-
minergic neurons in the SNc from DAT-Cre+/−::Arch3-GFP+/−
mice. Upon photostimulation, we observed an absence of
spikes (2.1 ± 0.5 Hz without light and 0 Hz with light, n= 5; with
Iinj= 0 pA) (Fig. 3b) and a hyperpolarization of the resting
SCH23390+sulpiride
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Fig. 3 eCB-LTP requires dopamine release during pairings and is D2R-dependent. a–d Induction of eCB-LTP requires dopamine release during the STDP
paired-activity paradigm. a Double immunostaining for tyrosine hydroxylase (indicating dopaminergic cell bodies in SNc and dopaminergic afferences in
striatum; upper panels) and GFP (indicating Arch3-expression; middle panels) in SNc (left panels) and in striatum (right panels); merge images are shown
in the lower panels. Scale bars: 500 µm (SNc) and 50 µm (striatum). b Spontaneous firing of dopaminergic neurons recorded in cell-attached mode in DAT-
Cre+/−::Arch3-GFP+/− mice with and without light (upper traces). Summary graph showing all experiments performed in DAT-Cre+/−::Arch3-GFP+/− mice
with and without opto-inhibition. c 15 post-pre pairings induced tLTP (n= 8, 6/8 cells showed tLTP) in DAT-Cre+/−::Arch3-GFP+/− mice without opto-
stimulation (LED off), while opto-stimulation (LED on) during STDP pairings prevents tLTP induction (n= 6, 1/6 cells showed tLTP). This illustrates that
eCB-tLTP requires DA release during STDP pairings. d 15 post-pre pairings induced tLTP with concomitant opto-stimulation (16 s duration) during STDP
protocol in DAT-Cre−/−::Arch3+/+ mice (n= 7, 6/7 cells showed tLTP). In panels (b–d), the yellow areas illustrate when LED was on to promote an opto-
inhibition. e, f 10 post-pre pairings (−30 <ΔtSTDP < 0ms) induced tLTP is D2R-activation dependent. Summary of STDP experiments showing that eCB-
tLTP induced with 10 post-pre pairings (n= 10) is prevented by the co-application of antagonists of D1R and D2R, SCH23390 (4 µM) and sulpiride (10 µM)
(n= 9, 8/9 cells showed tLTD and 1/9 showed no plasticity) (e), and with the D2R antagonist, sulpiride (10 µM, n= 8, 0/8 cells showed tLTP and
5/8 showed tLTD) but tLTP was left unaffected by the sole application of the D1R antagonist, SCH23390 (4 µM, n= 9, 8/9 cells showed tLTP) (f).
Representative traces are the average of 15 EPSCs during baseline (black traces) and 45min after STDP protocol (grey traces). Vertical grey dashed line
indicates the STDP protocol. Error bars represent sem. *p < 0.05; **p < 0.01; ***p < 0.001; ns: not significant by one sample t-test (c–f)
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membrane potential (−19 ± 5 mV, n= 5; with Iinj= 100 pA). We
first verified that few pairings successfully induced tLTP (without
photostimulation) in DAT-Cre+/−::Arch3-GFP+/− mice; we
observed tLTP with 15 post-pre pairings (143 ± 12%, p= 0.0091,
n= 8; Fig. 3c). 5–10 post-pre pairings (with a single postsynaptic
spike) were sufficient to induce potent tLTP in rat whereas in
C57BL/6 mice 15 pairings (with 2–3 postsynaptic spikes) were
necessary to trigger tLTP. In DAT-Cre+/−::Arch3-GFP+/− mice,
photostimulation concomitantly with the STDP protocol pre-
vented tLTP (102 ± 8%, p= 0.7943, n= 6; Fig. 3c). Here, the 16s
photostimulation of Arch3 was far below artifactual local trans-
mitter release reported for long (5 min) Arch3 activation41. As a
control we ensured that photostimulation itself in DAT-Cre−/−::
Arch3-GFP+/− mice did not impair tLTP induction: tLTP was
induced with 15 post-pre pairings applied concomitantly with
photostimulation (140 ± 12%, p= 0.0151, n= 7; Fig. 3d). There-
fore, dopamine release during the STDP pairings is necessary for
the induction of eCB-tLTP.
eCB-tLTP and -tLTD depend on distinct dopamine receptor. In
the striatum, the principal subtypes of dopamine receptors are D1
and D2 receptors33. These receptors have opposite effects: D1R
activates adenylyl cyclase and PKA via Golf-coupled receptor
signaling, and D2R inhibits them via Gi/o-coupled receptor. We
questioned which dopaminergic receptor subtype was involved in
eCB-tLTP induced by 10 post-pre pairings. Bath-applied
SCH23390 (4 µM, a D1R antagonist) and sulpiride (10 µM, a
D2R antagonist) prevented eCB-tLTP. Indeed, we even observed a
depression instead of tLTP (77 ± 4%, p= 0.0002, n= 9; Fig. 3e).
We next selectively inhibited either D1R or D2R. When we
inhibited D1R (SCH23390), we observed tLTP (169 ± 21%, p=
0.0113, n= 9) while no tLTP could be elicited with sulpiride (73
± 8%, p= 0.0117, n= 8) (Fig. 3f). Hence, we observed that the
prolonged inhibition of D2R (as well as both D1R and D2R)
flipped tLTP into tLTD. In an attempt to determine whether D2R
and CB1R share a common, parallel, or cooperative pathway42,
we next bath-applied quinpirole (10 µM), a D2R agonist, con-
comitantly with 10 post-pre pairings, and observed tLTP (146 ±
16%, p= 0.0334, n= 6; Supplementary Fig. 3), which was not
different from the control tLTP (p= 0.1871). This observation is
not in favor of cooperative or common pathways hypothesis for
D2R and CB1R, but points more likely toward parallel pathways42.
Secondly, we compared the dependence on dopamine receptor
subtypes of eCB-tLTP with eCB-tLTD. We observed that the
eCB-tLTD induced by 100 pre-post pairings was impaired by
SCH23390 and sulpiride, (106 ± 14%, p= 0.6714, n= 6; Supple-
mentary Fig. 4a). We next selectively inhibited either D1R or D2R
subtypes. The plasticity induced by 100 pre-post pairings was lost
(105 ± 16%, p= 0.7405, n= 8) when we inhibited D1R with
SCH23390, whereas we observed tLTP, instead of tLTD, with
sulpiride (199 ± 36%, p= 0.0335, n= 7; Supplementary Fig. 4b).
Altogether, these experiments indicate that eCB-tLTP is D2R-
mediated but does not depend on D1R whereas eCB-tLTD is
mediated by both D1R and D2R.
What is the location of the D2R required for eCB-tLTP? We
next questioned the location of the D2R involved in the induction
of eCB-tLTP. D2R are expressed at different locations in the
dorsal striatum: postsynaptically in D2R-expressing MSNs43 and
presynaptically in cholinergic interneurons44, nigrostriatal dopa-
minergic neurons45, and glutamatergic cortical afferents46,47
(Fig. 4a). To identify the D2R involved in the eCB-tLTP, we opted
for two complementary strategies: (1) we genetically-ablated
selectively D2R-MSN or cholinergic interneurons (using Cre-
mediated expression of the diphtheria toxin receptor (DTR) and
stereotaxic diphtheria toxin (DT) injection48) and 6-ODHA-
ablated selectively dopaminergic cells in the medial forebrain
bundle (MFB), and (2) we selectively knocked-out the D2R
expressed at D2R-MSN, cholinergic interneurons, dopaminergic
cells, or corticostriatal glutamatergic terminals, and next exam-
ined whether eCB-tLTP could still be observed (Fig. 4a). Note
that it was not possible to use the first strategy (i.e., genetic
ablation) for corticostriatal afferents without impairing the cor-
ticostriatal transmission.
D2R on D2R-MSNs are not required for eCB-tLTP. We first
questioned the postsynaptic localization of the D2R involved in
eCB-tLTP at the level of the MSNs (Fig. 4a). Due to the segre-
gation of expression of D1R and D2R among MSNs in mice
(D1R-like and D2R-like for the direct and indirect pathways,
respectively)43, roughly half of the MSNs are expected to be
D2R-expressing neurons. If eCB-tLTP was supported by the
postsynaptic D2R MSNs, one would expect to induce eCB-tLTP
in ~50% of the (randomly chosen) recorded MSNs. eCB-tLTP
was successfully induced in 83% (n= 27) of the (randomly
chosen) recorded MSNs, which does not favor the hypothesis of
involvement of D2R expressed by MSNs in eCB-tLTP. To confirm
this, we used transgenic D1R-eGFP mice to induce eCB-tLTP
specifically in D1R-eGFP+ or non-D1R-eGFP+ MSNs (Fig. 4b, c).
We observed tLTP in both D1R-eGFP+ (148 ± 8%, p= 0.0033,
n= 6; Fig. 4b) and non-D1R-eGFP+ (150 ± 7%, p= 0.0006, n= 7;
Fig. 4c) MSNs, indicating that tLTP can be induced in both
striatopallidal and striatonigral MSNs and that a postsynaptic
D2R in MSNs is a priori less likely to be involved in eCB-tLTP.
To further test the involvement of the D2R-MSNs, we
selectively ablated these neurons by Cre-mediated expression
of DTR and DT injection48. To inactivate D2R in the specific
neuronal population in the striatum of adult mice we use genetic
ablation to avoid developmental effect or compensation. More-
over, it has been shown that the ablation of 40–45% of the striatal
neurons in adult mice has no noticeable effect on others neuronal
populations48. We placed Cre recombinase under the control
of A2AR promoter because in the striatum A2AR expression
is restricted to D2R-MSNs. The DT was stereotaxically injected
into the dorsal striatum to produce ablation of D2R-MSNs.
In those A2A-Cre+/−::iDTR+/−::Drd1a-GFP+/− transgenic mice
after stereotaxic injection of DT, we found no detectable D2R+
cells but only D1R-GFP MSNs, whereas in the contra-lateral
hemisphere where DT had not been injected both populations of
D1R+- and D2R+-MSNs were observed (Fig. 4d). Whole-cell
recordings of D1R-GFP MSNs, from A2A-Cre+/−::iDTR+/−::
Drd1a-GFP+/− mice injected bilaterally with DT, showed
that 15 post-pre pairings were still able to cause tLTP (146 ±
7%, p= 0.0007, n= 7; Fig. 4e). As a control, we similarly injected
DT in mice lacking DTR expression (A2A-Cre−/−::iDTR+/−::
Drd1a-GFP+/−) and also observed tLTP (137 ± 10%, p= 0.0174,
n= 6; Supplementary Fig. 5a) that was not different from tLTP
obtained with ablation of D2R-MSN (p= 0.3566).
We next generated selective conditional knock-out (cKO) mice
for D2R expressed by D2R-MSN (A2A-Cre+/−::Drd2LoxP/LoxP
mice). We observed expression of tLTP induced by 15 post-
pre pairings in MSNs from A2A-Cre+/−::Drd2LoxP/LoxP mice
(181 ± 24%, p= 0.0192, n= 6; Fig. 4f). As the Cre driver control,
we used the A2A-Cre+/−::Drd2Wt/Wt mice and observed tLTP
following 15 post-pre pairings (172 ± 18%, p= 0.0070, n= 7;
Fig. 4g), which was not different from tLTP observed in
A2A-Cre+/−::Drd2LoxP/LoxP mice (p > 0.9999).
These results show that postsynaptic D2R located on D2R-
MSNs are not required for eCB-tLTP but thus should rely on
the activation of presynaptically located D2R.
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Fig. 4 eCB-tLTP does not depend on D2R expressed by D2R-MSNs. a Location of D2R in striatum expressed in striato-pallidal MSNs, cholinergic
interneurons, SNc dopaminergic and cortical glutamatergic afferents. Right: the two complementary strategies to identify the D2R involved in eCB-tLTP:
(1) genetic-ablation of D2R-MSN or cholinergic interneurons (using DTR and stereotaxic DT injection) and 6-ODHA-ablation of dopaminergic cells in the
MFB, and (2) D2R-cKO in D2R-MSN, cholinergic interneurons, dopaminergic cells, or corticostriatal glutamatergic afferents; NA accounts for the
impossibility to use a genetic-ablation of corticostriatal afferents without losing the studied EPSCs. b, c tLTP induced with 15 post-pre pairings is observed
in both striato-nigral (D1R-eGFP positive neurons, D1R-eGFP+, n= 6, 5/6 cells showed tLTP) (b) and striato-pallidal (D1R-eGFP negative neurons, non-
D1R-eGFP+, n= 7, 7/7 cells showed tLTP) (c) MSNs. d, e Experiments of plasticity expression in genetically-ablated mice for A2A-expressing neurons in
the dorsal striatum. d In situ hybridization autoradiograms (left) and quantification (right bar graph, n= 5 mice) of enkephalin mRNA in striatum caudal
level of coronal sections in A2A-Cre+/−::iDTR+/−::Drd1a-GFP+/− mice injected with DT stereotaxically in the dorsal striatum (right hemisphere) and without
DT injection (left hemisphere). Scale bars: 1000 µm. e In mice in which D2R-MSNs were ablated (A2A-Cre+/−::iDTR+/−::Drd1a-GFP+/− mice injected with
DT stereotaxically in the dorsal striatum) tLTP was induced with 15 post-pre pairings (n= 7, 7/7 cells showed tLTP). f, g Experiments of plasticity
expression in selective cKO for D2R expressed by striatal D2R-MSNs. f In mice in which D2R was specifically knocked-out in D2R-MSNs (A2A-Cre+/−::
Drd2LoxP/LoxP mice) tLTP was induced with 15 post-pre pairings (n= 6, 5/6 cells showed tLTP). g tLTP was observed in mice serving as the Cre driver
control (A2A-Cre+/−::Drd2Wt/Wt mice, n= 7, 6/7 cells showed tLTP). Representative traces are the average of 15 EPSCs during baseline (black traces)
and 45min after STDP protocol (grey traces). Vertical grey dashed line indicates the STDP protocol. Error bars represent sem. *p < 0.05; **p < 0.01;
***p < 0.001 by one sample t-test (b, c–g) or Wilcoxon Signed rank test (b)
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D2R on cholinergic interneurons are not required for eCB-
tLTP. Next, we first selectively ablated striatal cholinergic inter-
neurons by Cre-mediated expression of DTR and DT injection to
test the participation of the D2R express by striatal cholinergic
interneurons in eCB-tLTP (Fig. 5a). Cre recombinase was under
the control of ChAT promoter because in the striatum ChAT
expression is restricted to cholinergic interneurons. Ablation of
cholinergic interneurons was induced by DT, which was stereo-
taxically injected into the dorsal striatum. We verified that in
ChAT-Cre+/−::iDTR+/− mice, there was no detectable ChAT cells
after stereotaxic injection of DT whereas in the contra-lateral
hemisphere (without DT injection) a positive ChAT staining was
observed (Fig. 5a). In ChAT-Cre+/−::iDTR+/− mice injected
bilaterally with DT, 15 post-pre pairings induced tLTP (161 ±
20%, p= 0.0182, n= 8; Fig. 5b). We verified that this tLTP was
D2R-mediated by applying sulpiride (10 µM) and no plasticity
was observed (99 ± 10%, p= 0.9160, n= 6; Fig. 5b). As a further
control, we similarly injected DT in mice lacking DTR expression
(ChAT-Cre−/−::iDTR+/−) and observed a tLTP (150 ± 13%, p=
0.0171, n= 5; Supplementary Fig. 5b) that was similar to tLTP
obtained with ablation of cholinergic interneurons (p= 0.8221).
In the second step, we generated selective cKO mice for D2R
expressed in cholinergic interneurons (ChAT-Cre+/−::Drd2LoxP/
LoxP mice). In ChAT-Cre+/−::Drd2LoxP/LoxP mice, 15 post-pre
pairings induced tLTP in MSNs (169 ± 18%, p= 0.0111, n= 6;
Fig. 5c). As the Cre driver control, we used the ChAT-Cre+/−::
Drd2Wt/Wt mice and observed tLTP following 15 post-pre
pairings (135 ± 9%, p= 0.0175, n= 5; Fig. 5d), which was not
different from tLTP observed in ChAT-Cre+/−::Drd2LoxP/LoxP
mice (p= 0.0823).
These results indicate that eCB-tLTP does not depend on D2R-
activation located in cholinergic interneurons.
D2R on dopaminergic neurons are not required for eCB-tLTP.
To evaluate the potential role of presynaptic D2R in the dopa-
minergic neurons, we first lesioned dopaminergic neurons with 6-
OHDA. We performed in vivo stereotaxic 6-OHDA injection
(with desipramine) within the MFB of P35 rats (Fig. 6a) and
striatal TH staining was decreased by 77 ± 3% (p < 0.0001, n= 8)
2 weeks after lesion at P50 (Fig. 6b). In parallel, we used control
(P50 rats without any surgery) and sham-operated (P35 rats with
saline injection instead of 6-OHDA and recorded at P50) animals
(Fig. 6c and Supplementary Fig. 5c). We first verified that tLTP
was induced with 10 post-pre pairings in P50 control rats (158 ±
16%, p= 0.0168, n= 6; Supplementary Fig. 5c) and sham-
operated rats (147 ± 10%, p= 0.0032, n= 7; Fig. 6c); both tLTP
show similar magnitude (p= 0.7133). As expected, in 6-OHDA
animals we did not observe any plasticity with 10 post-pre pair-
ings (90 ± 7%, p= 0.1916, n= 7; Fig. 6c). We next bath-applied
quinpirole (10 µM), a selective agonist of D2R, to overcome the
lack of dopamine, and tLTP was observed (141 ± 9%, p= 0.0076,
n= 6; Fig. 6d); this tLTP was not different from those observed in
sham-operated rats (p= 0.7984). In conclusion, tLTP could be
observed (with quinpirole) in 6-OHDA-lesioned animals.
In the second step, we generated selective cKO mice for D2R
expressed in dopaminergic cells (DAT-Cre+/−::Drd2LoxP/LoxP
mice). Whole-cell recordings of MSNs from DAT-Cre+/−::
Drd2LoxP/LoxP mice showed that 15 post-pre pairings induced
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ChAT-Cre+/– :: Drd2 LoxP/LoxP mice
ChAT-Cre+/– :: iDTR +/– mice
ChAT-Cre +/– :: Drd2Wt/Wt mice
a b
c d
Fig. 5 eCB-tLTP does not depend on D2R expressed by cholinergic interneurons. a, b Experiments of plasticity expression in genetically-ablated mice for
ChAT-expressing neurons in the dorsal striatum. a ChAT immunostaining in ChAT-Cre+/−::iDTR+/− (left panels) mice injected with DT stereotaxically in the
dorsal striatum (right hemisphere) and without DT injection (left hemisphere); quantification (right bar graph) of the number of Ach-positive cells per
striatal slices (n= 6 mice). b tLTP was induced with 15 post-pre pairings in ChAT-Cre+/−::iDTR+/− mice (n= 8, 8/8 cells showed tLTP) injected bilaterally
with diphtheria toxin in the dorsal striatum. tLTP observed in cholinergic interneuron-ablated mice was D2R-mediated because it was prevented by sulpiride
(10 µM, n= 6, 2/6 cells showed tLTP). c, d STDP expression in selective cKO for D2R expressed by cholinergic interneurons. c In mice in which D2R was
specifically knocked-out in cholinergic interneurons (ChAT-Cre+/−::Drd2LoxP/LoxP mice) tLTP was induced with 15 post-pre pairings (n= 6, 6/6 cells showed
tLTP). d tLTP was observed in mice serving as the Cre driver control (ChAT-Cre+/−::Drd2Wt/Wt mice, n= 5; 4/5 cells showed tLTP). Representative traces
are the average of 15 EPSCs during baseline (black traces) and 45min after STDP protocol (grey traces). Vertical grey dashed line indicates the STDP
protocol. Error bars represent sem. *p < 0.05; ***p < 0.001; ns: not significant by Wilcoxon Signed rank test (a) or one sample t-test (b–d)
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control, we used the DAT-Cre+/−::Drd2Wt/Wt mice and observed
tLTP following 15 post-pre pairings (169 ± 22%, p= 0.0157, n=
8; Fig. 6f), which was not different from tLTP observed in DAT-
Cre+/−::Drd2LoxP/LoxP mice (p= 0.7193).
Altogether, these results show that presynaptic D2R located
on nigrostriatal dopaminergic afferents are not required for
eCB-tLTP.
We recorded MSNs from Cre−/−::Drd2LoxP/LoxP mice as the
floxed gene control for the selective D2R-cKO mice experiments.
15 post-pre pairings induced tLTP in Cre−/−::Drd2LoxP/LoxP mice
(156 ± 12%, p= 0.0052, n= 7; Supplementary Fig. 5d). We did not
observe any difference between tLTP recorded in MSNs in
the floxed gene control (Cre−/−::Drd2LoxP/LoxP mice) and the Cre
driver controls (A2A-Cre+/−::Drd2Wt/Wt, ChAT-Cre+/−::Drd2Wt/Wt,
and DAT-Cre+/−::Drd2Wt/Wt mice) (ANOVA, p= 0.5524).
eCB-tLTP depends on D2R in corticostriatal pyramidal cells.
We next selectively inactivated D2R at corticostriatal
glutamatergic afferents by cKO to test the implication of the D2R
expressed by neocortical pyramidal cells in eCB-tLTP (Fig. 7).
Bilateral KO of D2R in pyramidal cells was obtained by the
stereotaxic injection of AAV-cre-GFP (AAV1.CMV.HI.eGFP-Cre.
WPRE.SV40) in the layer 5 of the somatosensory cortex of
D2RLoxP/LoxP mice (Fig. 7a). In D2RLoxP/LoxP mice injected with
AAV-cre-GFP, we did not observe detectable positive immunos-
taining for D2R expression in pyramidal cells (Fig. 7b), whereas
positive cells were observed in D2RLoxP/LoxP mice injected with
AAV-GFP (Fig. 7c); these later mice serving as control. Whole-
cell recordings of MSNs from D2RLoxP/LoxP mice injected bilat-
erally with AAV-cre-GFP, showed that 15 post-pre pairings
failed to induce tLTP, but tLTD was observed instead (60 ± 7%,
p= 0.0008, n= 8; Fig. 7d). As a control, we similarly injected
AAV-GFP in D2RLoxP/LoxP mice and observed tLTP induced by
15 post-pre pairings (150 ± 8%, p= 0.0025, n= 5) (Fig. 7e).
These results demonstrate that eCB-tLTP depends on presynaptic
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Fig. 6 eCB-tLTP does not depend on D2R expressed by dopaminergic neurons. a–d Experiments of plasticity expression in 6-ODHA-ablated dopaminergic
cells in the MFB. a Scheme of the protocol showing the time course of the in vivo 6-OHDA lesions and ex vivo electrophysiological recordings. b Unilateral
6-OHDA injection in MFB led to degeneration of dopaminergic nigral neurons, illustrated by a loss of their striatal afferences as illustrating by the summary
bar graph of TH immunostaining quantification. Sham-operated rats display equivalent TH staining in both striata. c 10 post-pre pairings induced tLTP in
sham-operated (n= 7, 7/7 cells showed tLTP) rats whereas tLTP was impaired in 6-OHDA-lesioned rats (n= 7, 1/7 cells showed tLTP), and d rescued
with a D2R agonist, quinpirole (10 µM, n= 6, 5/6 cells showed tLTP). e, f STDP expression in selective cKO for D2R expressed by dopaminergic neurons.
e In mice in which D2R was specifically knocked-out in dopaminergic neurons (DAT-Cre+/−::Drd2LoxP/LoxP mice) tLTP was induced with 15 post-pre pairings
(n= 6, 6/6 cells showed tLTP). f tLTP was observed in mice serving as the Cre driver control (DAT-Cre+/−::Drd2Wt/Wt mice, n= 8; 6/8 cells showed
tLTP). Representative traces are the average of 15 EPSCs during baseline (black traces) and 45min after STDP protocol (grey traces). Vertical grey dashed
line indicates the STDP protocol. Error bars represent sem. *p < 0.05; **p < 0.01; ***p < 0.001; ns: not significant by Wilcoxon Signed rank test (b) or one
sample t-test (c–f)
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Dopamine and eCB-tLTP interaction: a mathematical model.
To provide hypotheses for the effects of the D2R inhibition/
deletion/cKO (Figs. 4–7), we developed a biologically plausible
mathematical model13 of corticostriatal synaptic plasticity. Our
model emulates the temporal dynamics of the signaling pathways
involved in corticostriatal STDP12,13,28,29,31,32, combining a
pathway leading from NMDAR to calmodulin and CaMKII with
a second one that links postsynaptically mGluR5 and cytosolic
calcium to eCB production and results in the activation of pre-
synaptic CB1R (Fig. 8a). Our model expresses chemical kinetics
for the reactions in these two pathways (Fig. 8a). Repeated pairing
stimulations of the pre- and postsynaptic neurons trigger tran-
sient changes of the species implicated in the biochemical reac-
tion network illustrated (Fig. 8a) according to standard mass-
action law kinetics. Hence, the temporal evolution of each species
emerges from the coupling between the reaction network and the
stimulations. We used the amount of phosphorylated post-
synaptic CaMKII as a proxy for the postsynaptic contribution to
the synaptic weight, while presynaptic Gi/o-GPCR activation by
CB1R and D2R was taken as a proxy for the presynaptic con-
tribution (see Methods). The total synaptic weight (Wtotal) was
computed as the product of pre- and postsynaptic
contributions13. Our model accounts for the outcome of plasticity
when the spike timing (ΔtSTDP), the frequency (Fpairings), and the
number (Npairings) of pairings are varied. The Wtotal changes for
Fpairings= 1 Hz and a range of −35 < ΔtSTDP <+35 ms and for 1
<Npairings < 100 values are illustrated by the color-map of Fig. 8b.
In agreement with experimental data12,13, the outcome of plas-
ticity is splitted along three plasticity domains: a first tLTP (i.e.,
eCB-tLTP) domain for −3 < ΔtSTDP <−25 ms and 3 <Npairings <
30, a second tLTP (i.e., NMDAR-tLTP) domain for −10 < ΔtSTDP
<−25 ms and Npairings > 50, and a tLTD (i.e., eCB-tLTD) domain
for 10 < ΔtSTDP < 25 ms and Npairings > 20. The quality of the
match between model prediction and electrophysiology mea-
surements is illustrated in Fig. 8c, d (see ref. 13, for a more
thorough account).
We next examined the dependence of plasticity on the
activation of dopamine receptors, since our model integrates
the dependence of plasticity on presynaptic D2R (see Methods).
We compared the changes of eCB-tLTP domain under pre-
synaptic D2R inhibition in the model against the data. Figure 8e
illustrates the changes experienced by the two eCB-controlled
domains when the level of presynaptic D2R activation decreases
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Fig. 7 eCB-tLTP depends on D2R expressed by cortical pyramidal cells. a GFP fluorescence in D2RLoxP/LoxP injected with AAV-cre-GFP in somatosensory
cortex. Left panel: site of injection of the AAV-cre-GFP and the resulting fluorescence in pyramidal cells in somatosensory cortex (scale bar: 250 µm). Note
that the fluorescence is restricted to neurons within cortex and does not cross corpus callosum (Cc). Right panel: GFP fluorescence in corticostriatal
afferents within dorsal striatum (scale bar: 100 µm). b, c D2R immunostaining in the somatosensory cortex of D2RLoxP/LoxP mice injected with AAV-cre-
GFP (b) or with AAV-GFP (c); (scale bar: 100 µm). d, e Experiments of plasticity expression in cKO mice for D2R expressed at corticostriatal glutamatergic
afferents. d 15 post-pre pairings failed to induce tLTP in D2RLoxP/LoxP mice injected with AAV-cre-GFP in somatosensory cortex (n= 8, 0/8 and 7/8 cells
showed tLTP and tLTD, respectively). e As a control, tLTP was induced with 15 post-pre pairings in D2RLoxP/LoxP mice injected with AAV-GFP (n= 5, 5/5
cells showed tLTP). Representative traces are the average of 15 EPSCs during baseline (black traces) and 45min after STDP protocol (grey traces). Vertical
grey dashed line indicates the STDP protocol. Error bars represent sem. **p < 0.01; ***p < 0.001 by one sample t-test (d, e)
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0.50, 0.25, and 0.00; see Methods). The eCB-tLTD domain (for
ΔtSTDP around +20 ms) is not affected by the decrease of
presynaptic D2R signaling. In contrast, eCB-tLTP (centered on
Npairings= 15 and ΔtSTDP=−15 ms) is altered by a reduction of
presynaptic D2R signaling: eCB-tLTP magnitude first decreases
and is then replaced by eCB-tLTD. Therefore, our model predicts
that blockers of presynaptic D2R do not affect eCB-tLTD and
convert eCB-tLTP into tLTD; the latter prediction matches with
the experimental data (Figs. 3f and 7d).
We next analyzed the dynamics of the model to explain this
progressive change of eCB-tLTP to no plasticity then to eCB-
tLTD as D2R inactivation increases. The variable yG summarizes
the effects of CB1R and D2R activation on the presynaptic weight
(Wpre). We assumed that the effects of D2R and CB1R are
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cumulative, up to the tLTP threshold. We expressed this
assumption mathematically by the linear combination of three
terms: yG= kCB1R⋅xCB1R+ γD2R⋅DA+ γother. The first term, pre-
synaptic CB1R activation (xCB1R) is controlled by
postsynaptically-produced eCBs (see Methods), the dynamics of
which comprises calcium-dependent biochemical reactions. Since
postsynaptic calcium dynamics in our model emerges from the
interaction between the paired stimulations and the biochemical
network, yG dynamics indirectly depends on spike timing via the
calcium-dependence of xCB1R. The second term depends on D2R
activation (γD2R⋅DA) and, the third one, γother accounts for
background activation of the Gi/o-GPCR pathway not related to
D2R and CB1R.





LTP): Wpre drops (LTD) when yG is in between
θstartLTD and θ
stop
LTD, whereas Wpre rises (LTP) if yG becomes larger
than θstartLTP (Fig. 8f, dashed line). In control conditions (Fig. 8f, red
line), the combination of the effect of CB1R activation by eCBs
(produced upon the STDP protocol) and that of D2R by (tonic)
dopamine, build up to yield yG levels (red) that overcome θ
start
LTP
resulting in LTP. However, with D2R activation blocked (Fig. 8f,
blue line), yG cannot reach θ
start
LTP , thus effectively preventing the
expression of eCB-tLTP. Nevertheless, yG still crosses the LTD
range with LTD accumulating in proportion to the time spent
between θstartLTD and θ
stop
LTD. As a result, eCB-tLTD is expressed
instead of eCB-tLTP. This is in agreement with our experimental
data (Figs. 3f and 7d) in which the prolonged inhibition or
deletion of D2R switched eCB-tLTP into tLTD, whereas brief (16
s) opto-inhibition prevented eCB-tLTP without conversion into
tLTD (Fig. 3c). Therefore, according to the model, the switch
from eCB-tLTP to eCB-tLTD observed when presynaptic D2R are
blocked is due to the reduction of the synergestic effect of D2R on
the presynaptic terminal that needs to be present in addition to
the activation of the presynaptic Gi/o-GPCR pathway by CB1R to
reach θstartLTP . Thus, the presynaptic cortical D2R not only allow the
expression of eCB-tLTP, but even control the polarity (LTP vs
LTD) of the plasticity induced by a low number of pairings.
The above results (experimental and theoretical) consider 1 Hz
stimulations. In the neocortex, increasing Fpairings with large
numbers of pairings promotes tLTP at the expense of tLTD49. We
next used the model to address the effects of D2R block on STDP
when Fpairings varies (Supplementary Fig. 6). Note that our model
was calibrated based on experimental data harvested at 1 Hz and
does not account for the complex frequency-dependence of
glutamate signaling (glutamate release and uptake, AMPAR
desensitization). For this reason, our previous investigations13
have shown that sensitivity to frequency changes is larger in the
model than in the experiments, so that the effects of a small
change of Fpairings in the model (1.00–1.05 Hz) are similar to the
effects of larger changes (1–3 Hz) in the experiments (see
Discussion). In control conditions (100% D2R activation) and
small numbers of pairings (Npairings < 25 and ΔtSTDP < 0), eCB-
tLTP is not expressed when Fpairings < 0.9 Hz. However, eCB-tLTP
is not much altered above the threshold (Supplementary Fig. 6b,
6d and 6f). Note that eCB-tLTD observed at negative ΔtSTDP
(blue areas in Supplementary Fig. 6b) is in all case negligible in
control conditions for Npairings < 25. When presynaptic D2R are
blocked (Supplementary Fig. 6a) the model shows a similar
picture, but the frequency threshold for eCB-tLTP is larger than
1 Hz. This explains the disappearance of eCB-tLTP at 1 Hz when
D2R are blocked (Supplementary Fig. 6a). Moreover the faint
eCB-tLTD present in control conditions at ΔtSTDP < 0 is amplified
in the absence of D2R activation (Supplementary Fig. 6a, blue
areas for Npairings < 25, ΔtSTDP < 0). This explains the emergence
of eCB-tLTD at 1 Hz when D2R are blocked.
The impact of Fpairings on STDP is quite different with larger
pairings (Npairings > 50). In control conditions (100% D2R
activation), the expression domain of NMDAR-tLTP (Npairing >
50, ΔtSTDP < 0) enlarges drastically when Fpairings increases
(Supplementary Fig. 6b and 6d). NMDAR-tLTP even invades
the quadrant of positive ΔtSTDP (Supplementary Fig. 6f).
This strengthening of NMDAR-tLTP with increased Fpairings
matches published experimental reports49,50. In comparison, the
expression of eCB-tLTD with such large pairings (Npairings > 50,
ΔtSTDP > 0) is not much altered by large frequencies. Since
presynaptic D2R in the model only affects eCB plasticity, blocking
D2R receptors has no effect on NMDAR-tLTP directly (Supple-
mentary Fig. 6a, 6c and 6e, Npairings > 50, ΔtSTDP < 0), although
it strengthens eCB-tLTD, thus partially canceling NMDR-
tLTP. To summarize, at Fpairings>1 Hz our model predicts that
presynaptic D2R signaling fine-tunes STDP polarity (LTP or
LTD) via the control of eCB-plasticity.
Hyperdopaminergy in the striatum is of interest since observed
in drug addiction51. We next used our mathematical model to
explore the effects of hyperdopaminergy on STDP. Figure 8g
shows model prediction when the level of tonic dopamine is
increased threefold with respect to control. eCB-tLTP induction
is hardly altered by hyperdopaminergy. The main modification is
that larger Npairings can induce eCB-tLTP, so eCB-tLTP domain
fuses with the NMDAR-tLTP domain. In contrast, hyperdopa-
minergy has a drastic effect on eCB-tLTD: the whole eCB-tLTD
domain disappears so pre-post pairings fail to induce any
Fig. 8 Threshold-based model interaction between dopamine and eCB-STDP. a Scheme of the modeled signaling network. The NMDAR-based pathway
sets the postsynaptic weight Wpost as the phosphorylation state of CaMKIIα. In the second pathway, coincident activation of phospholipase-Cβ by
postsynaptic mGluR and calcium entry via VSCC and TRPV1 induces eCB production (2-AG and AEA). eCBs activates CB1R which modulates Wpre, and
Wtotal=Wpost ×Wpre. In the model, D2R in the presynaptic cortical neurons co-localize with CB1R, so the effects of D2R and CB1R activations cumulate to
determine whether the threshold for eCB-tLTP is reached. As a result, D2R activation by dopamine also contributes to Wpre changes. Green disks indicate
calcium-dependent steps. For a thorough description, see ref. 13. Abbreviations: PIP2 phosphatidylinositol 4,5-biphosphate; DAG diacylglycerol; IP3
inositol-1,4,5-triphosphate; PLCβ/δ phospholipase-Cβ/δ; DAGLα diacylglycerol lipase-α; 2-AG 2-arachidonoylglycerol; AEA anandamide; IP3R IP3-receptor
channel; SERCA sarcoplasmic/endoplasmic reticulum calcium ATPase; CaER calcium in the endoplasmic reticulum; (Ca)4CaM fully bound calmodulin; CaN
calcineurin aka PP2B; I1p/I1 phosphorylated/unphosphorylated protein phosphatase-1 inhibitor-1 (DARPP-32 in MSNs); PP1 protein phosphatase-1; CaMKII
Ca2+/calmodulin-dependent protein kinase-II. b Model prediction for Wtotal changes (LTP and LTD) with varying Npairings and ΔtSTDP (at 1 Hz) shows eCB-
tLTP (3 < Npairings < 40, −10 <ΔtSTDP <−25ms) and the eCB-tLTD domains (Npairings > 70, +10 <ΔtSTDP <+25ms). c, d Changes ofWtotal with ΔtSTDP, for
Npairings= 10 (c) or 100 (d) pairings at 1 Hz. Black lines are simulation results whereas the black circles show experimental measurements. e Wtotal change
map of b when presynaptic D2R activation is reduced from 100 to 0% of the control (shown in b). f Temporal evolution of yG, that combines the effects of
D2R and CB1R activation during STDP protocol (10 pairings at 1 Hz, ΔtSTDP=−15 ms). LTD is triggered when yG is between θstartLTD and θ
stop
LTD whereas LTP is
triggered when yG > θ
start
LTP . D2R activation was 100% (red full line) or 0% (blue full line). g Model prediction for Wtotal upon hyperdopaminergy, with a
threefold increase of tonic dopamine (DA, see Supplementary Experimental Procedures) compared to the control case shown in b. All other parameters
were as in b
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plasticity regardless Npairings or ΔtSTDP (Fig. 8g). With large D2R




LTP , which is
too large to induce LTD but too weak to trigger LTP. Therefore,
the prediction of our model is that hyperdopaminergy (via
activation of presynaptic cortical D2R), should prevent eCB-tLTD
and considerably extend the domain of expression of eCB-tLTP.
Discussion
Corticostriatal long-term plasticity provides a fundamental
mechanism for the function of the basal ganglia in procedural
learning14–19,21,52. We uncovered the existence of striatal eCB-
tLTP that relies on of CB1R and TRPV1 activation and is induced
by a low number of pairings12,13. eCB-tLTP requires high levels of
CB1R activation that can be reached with 10–15 post-pre pairings.
Indeed, for such Npairings, eCB synthesis and release would con-
tribute maximally to presynaptic CB1R activation (maximal
cytosolic calcium influx from NMDAR, VSCC, TRPV1, and
maximal calcium efflux from internal stores, combined with a
minimal CB1R desensitization)13. According to our mathematical
model, beyond 30 post-pre pairings, calcium efflux from the
internal calcium stores decreases (because of a sub-optimal cal-
cium refilling of the internal stores) while CB1R desensitization
increases concomitantly. CB1R activation then crosses θ
start
LTP
(Fig. 8f), so that eCB-tLTP vanishes, and NMDAR-tLTP can be
expressed for post-pre Npairings > 50 (Fig. 8b; see ref. 13). Inter-
estingly, GABAergic microcircuits are not involved in eCB-tLTP
induction or magnitude at corticostriatal synapses, but control
eCB-tLTP polarity12. eCBs have been mainly reported to depress
synaptic weight through the activation of CB1R or TRPV11,2. This
view is now challenged by studies reporting opposite effects
(potentiation) in various brain structures using various signaling
pathways3–13. We describe here and in previous studies11–13,50 a
tLTP in mammals, wherein eCB signaling directly underlies both
the induction and the long-term maintenance of synaptic weight
increase.
Our mathematical model is sensitive to Fpairings (Supplemen-
tary Fig. 6). The results predicted by the model for small fre-
quency changes (from 1.0 to 1.2 Hz) match well the results we
obtained experimentally with larger frequency changes (from 1 to
3 Hz). This distortion may be due to the numerous frequency-
dependent mechanisms (glutamate release or uptake, AMPAR
desensitization) that buffer the effects of Fpairings increase in the
experiments. For instance, the amount of glutamate released
upon presynaptic stimulation does not depend on the frequency
of presynaptic stimulation in the model. Therefore, the impact
of increased frequency on the amplitude of the calcium trace
is larger than in the experiments where presynaptic short-
term plasticity decreases the amount of released glutamate when
presynaptic frequency increases53, thus compensating for the
effects of frequency increase on the calcium traces. Those
frequency-dependent mechanisms could have been accounted for
but would have been at the expense of a further complexification
of the model.
Dopamine is a key actor of action selection and associative
learning22 and for the modulation of striatal projection24,25,33.
Electrical, chemical, or transcranial stimulation in different cor-
tical areas enhances dopamine release in the corresponding
projecting striatal areas including the dorsal striatum38–40. Our
results show that dopamine is a key element for eCB-tLTP
expression through the activation of D2R. Contrarily to eCB-LTD
induced with high- or low-frequency stimulation protocol24,25
(i.e., a rate-coding paradigm), eCB-tLTP (induced here with a low
number of STDP pairings, i.e., a time-coding paradigm) does not
require postsynaptic D2R expressed by striatopallidal neurons.
Indeed, the selective ablation of those D2R-MSNs or the selective
D2R cKO in D2R-MSNs failed to prevent eCB-tLTP. Moreover,
we observed eCB-tLTP in D1R-expressing MSNs as well as D1R-
non-expressing cells. This demonstrates that D2R involved in
eCB-tLTP have a presynaptic location. The presynaptic D2R
are expressed at three different locations: the nigrostriatal dopa-
minergic afferents45, the cholinergic interneurons44, and the
corticostriatal glutamatergic afferents46,47. Presynaptic D2R in
nigrostriatal dopaminergic afferents and cholinergic interneurons
are not required for eCB-tLTP as demonstrated by ablation or
selective D2R cKO experiments. Although eCB-tLTP is mus-
carinic M1R-mediated13, eCB-tLTP was observed with ablated
cholinergic interneurons suggesting that M1R should have a
constitutive activity54. Moreover, the involvement of D2R
expressed by cholinergic interneurons is unlikely since the acti-
vation of those D2R would decrease acetylcholine release,
promoting LTD, and not LTP55. eCB-tLTP was absent in mice in
cKO of D2R in the somatosensory cortex. Those results unam-
biguously demonstrate that D2R implicated in the control of eCB-
tLTP are located on the presynaptic pyramidal neurons, where
the CB1R are also expressed. Interestingly, eCB-LTD (rate-coded)
has been reported to be tightly controlled by D2R expressed
by striatal cholinergic interneurons55,56 or by D2R-MSNs57,58
(for review see ref. 24), i.e., distinct pools of D2R are engaged in
eCB-LTD and eCB-LTP. In the nucleus accumbens, activation of
CB1R on cortical terminals limits dopamine release and governs
reward-driven behavior59. Dopamine–eCB interactions remain
to be examined in dorsal striatum in the temporal-credit
assignment problem60–62.
Colocalization of D2R and CB1R on the same presynaptic
terminals would act synergistically on adenylate cyclase activity
and promote eCB-tLTP or eCB-tLTD induced by small numbers
of pairings, depending on the activation of D2R and CB1R. Our
results suggest a joint CB1R- and D2R-control of STDP whereby
the same signal, adenylate cyclase or PKA activity, can trigger
tLTP or tLTD depending on the dynamics of the signaling
pathway13. A similar hypothesis has been proposed for NMDAR-
dependent STDP where the outcome of plasticity depends on the
dynamics of intracellular calcium63,64. However our results
unravel further complexity of the system, since in our hands
the eCB-tLTD induced with 100 pairings shows additional
dependence on D1R (both D2R- and D1R-mediated). This result
matches some of the earlier results on corticostriatal STDP28;
but see the STDP with 100 pairings at 0.1 Hz in which tLTD was
D1R- but not D2R-dependent29. We observed that in both cases,
pharmacological blocking of D2R gave rise to a switch of plasti-
city: with 100 pre-post pairings, tLTP was obtained instead of
eCB-tLTD, whereas with 10 post-pre pairings D2R inhibition
resulted in tLTD instead of eCB-tLTP; note that the inhibition of
D1R has no effect on eCB-tLTP and prevents eCB-tLTD. Inter-
estingly, only prolonged inhibition of D2R (pharmacological and
genetic deletion experiments) switched eCB-tLTP into tLTD
whereas a brief (16 s) opto-inhibition of dopamine release during
STDP pairings prevented eCB-tLTP without inducing tLTD. We
hypothesize that opto-inhibition likely prevents phasic dopamine
release during STDP pairings without affecting much background
tonic dopamine levels whereas prolonged inhibition of D2R
would affect preferentially the tonic component. D2R have been
widely described to efficiently sense the tonic dopamine because
of their high affinity for dopamine65, but D2R can also encode
phasic dopamine signals66. This suggests that depending on the
level of the tonic dopamine, D2R would favor either eCB-tLTP or
eCB-tLTD (for a low number of pairings). Thus, presynaptic
cortical D2R operate as gatekeepers for the expression and
polarity of corticostriatal eCB-STDP (eCB-tLTP and eCB-tLTD)
depending on the activity pattern. This could be linked to the role
of dopamine in the temporal credit-assignment by operating a
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retroactive control of STDP polarity, as demonstrated in stria-
tum60–62 or in hippocampus67.
Although, eCB-tLTP can be induced with 15 post-pre pairings
in D1R- and D2R-MSNs, it does not imply that in physiological
conditions eCB-tLTP would be equally triggered in these MSN
subpopulations. Indeed, D2R-MSNs are more excitable than D1R-
MSNs68 and thus would not integrate similarly incoming cortical
inputs, especially in the frame of a plasticity induced by a very low
number of pairings, such as eCB-tLTP. This differential mem-
brane excitability may be exacerbated by a higher excitability of
D2R-MSN dendrites, allowing back-propagating action potentials
to invade more efficiently distal dendrites in D2R-MSNs69. This is
of importance for STDP in which a back-propagating action
potential is triggered for every pairings. Therefore, one can expect
that eCB-tLTP would be more prone to occur in D2R- than in
D1R-MSN. It thus remains to investigate whether D2R-MSN
would have a proeminent role in the fast learning via expression
of eCB-tLTP. The use of noisy STDP pairings, to approach in-
vivo-like conditions, revealed that plasticity robustness depends
on the signaling pathways with eCB-tLTP and eCB-tLTD being
much more robust than NMDAR-tLTP50. In vivo conditions for
eCB-tLTP emergence, using naturalistic firing patterns recorded
across learning tasks still need to be determined.
Alterations of the eCB system seem to contribute to action-
learning defects in Parkinson’s disease24,34. So far, this alteration
was thought to rely on disruption of the well-characterized eCB-
LTD, which is D2R-dependent24,25. Here, we report that eCB-
tLTP is also D2R-dependent, is disrupted in a rodent model of
Parkinson’s disease, and can be rescued with L-DOPA treatment.
D2R are central in various psychiatric diseases70. According to
our findings, the effect of dopamine on corticostriatal STDP
would vary with the cellular location (MSN, cholinergic, dopa-
minergic, or neocortical neurons) of D2R and on the thalamus/
cortical activity regimes. It remains to analyze the effects of the
disruption of eCB-tLTP in vivo to address the roles of eCB-tLTP
in physiological and pathophysiological states. From our mathe-
matical model, it is expected that the eCB-tLTP expression
domain extends considerably under hyperdopaminergia. One
could thus speculate that psychostimulant drugs such as cocaine
or amphetamines (which trigger a hyperdopaminergia) would
promote eCB-tLTP and possibly facilitate the early phase of
learning. On the contrary, upon hypodopaminergia, it is expected
that LTD will take over instead of eCB-tLTP and thus affect the
fast learning. These predictions remain to be tested in the frame
of learning and memorizing salient events from a low number
of spikes20. Because it is induced by small numbers of pairings,
eCB-tLTP may represent a central molecular substrate for the
rapid learning of new arbitrary associative memories and beha-
vioral rules20 characterizing the flexible behavior of mammals
or during initial stages of slower habit learnings14,52, which
may possibly be disrupted in Parkinson’s disease24,34.
Methods
Animals. Sprague–Dawley rats (Charles River, L’Arbresle, France) and C57BL/6
mice (DAT-Cre, Archeorhodopsin3-GFP, Adora2a-Cre, inducible-DTR, Drd1a-
GFP, ChAT-cre and D2RLoxP/LoxP, A2A-Cre+/−::Drd2LoxP/LoxP, ChAT-Cre+/−::
Drd2LoxP/LoxP, DAT-Cre+/−::Drd2LoxP/LoxP mice) were used for electrophysiology,
in situ hybridization, and immunohistochemistry. Adora2a-Cre+/− transgenic mice
expressing the Cre recombinase under the control of the striatopallidal specific
adenosine A2A receptor (Adora2a) promoter48. C57BL/6 Adora2a-Cre+/− mice
were crossed with C57BL/6 iDTR+/+ mice71, and Drd1a-GFP+/+ resulting in 50%
triple-heterozygous Adora2a-Cre+/−::iDTR+/−::D1R-GFP+/− and 50% Adora2a-
Cre−/−::iDTR+/−::D1R-GFP+/− which were used as controls. C57BL/6 ChAT-Cre
+/− (JAX SN6410) mice were crossed with C57BL/6 iDTR+/+ mice71. Drd2 floxed
mice carrying two targeted loxP sites flanking Drd2 exon 272. The Cre-mediated
expression of Arch3 was obtained using mice expressing Cre-recombinase under
the control of the Slc6a3 promoter (DAT-Cre mice, JAX SN006660) and Rosa26
LSL Arch3-GFP (Jackson Laboratory). Mice were housed by groups of 3–5 mice, in
a 12 h light/dark cycle, with food and water available ad libitum. All experiments
were performed in accordance with local animal welfare committee (CIRB and
ULB Ethical Committees) and EU guidelines (Directive 2010/63/EU). Every
precaution was taken to minimize stress and the number of animals used in each
series of experiments.
Patch-clamp recordings and analysis. Corticostriatal connections (between
somatosensory cortex layer 5 and dorsal striatum) are preserved in a horizontal
plane30. Horizontal brain slices with thickness of 330 or 300 μm were prepared,
respectively, from rats (P(20–25) for most experiments, P50 for 6-OHDA lesion, and
P(60–65) for Parkinson’s disease animal model) or mice (P(25–45)) using a vibrating
blade microtome (VT1200S, Leica Microsystems, Nussloch, Germany). In a subset
of experiments, we performed coronal brain slices to record in cell-attached
dopaminergic neurons from the SNc. Brains were sliced in a 95% CO2/5%
O2-bubbled, ice-cold cutting solution containing (in mM) 125 NaCl, 2.5 KCl,
25 glucose, 25 NaHCO3, 1.25 NaH2PO4, 2 CaCl2, 1 MgCl2, 1 pyruvic acid, and
transferred into the same solution at 34 °C for 1 h and next moved to room
temperature.
Patch-clamp recordings were performed in the dorsolateral striatum12,32,35.
Borosilicate glass pipettes of 4–6MΩ resistance contained for whole-cell recordings
(in mM): 105 K-gluconate, 30 KCl, 10 HEPES, 10 phosphocreatine, 4 ATP-Mg, 0.3
GTP-Na, 0.3 EGTA (adjusted to pH 7.35 with KOH). The composition of the
extracellular solution was (mM): 125 NaCl, 2.5 KCl, 25 glucose, 25 NaHCO3, 1.25
NaH2PO4, 2 CaCl2, 1 MgCl2, 10 μM pyruvic acid bubbled with 95% O2 and 5%
CO2. Signals were amplified using EPC10-2 amplifiers (HEKA Elektronik,
Lambrecht, Germany). All recordings were performed at 34 °C using a temperature
control system (Bath-controller V, Luigs & Neumann, Ratingen, Germany) and
slices were continuously superfused at 2–3 ml/min with the extracellular solution.
Slices were visualized on an Olympus BX51WI microscope (Olympus, Rungis,
France) using a 4×/0.13 objective for the placement of the stimulating electrode and
a 40×/0.80 water-immersion objective for localizing cells for whole-cell recordings.
Current- and voltage-clamp recordings were filtered at 5 kHz and sampled at
10 kHz using the Patchmaster v2x32 program (HEKA Elektronik).
Off-line analysis was performed using Fitmaster (Heka Elektronik) and
Igor-Pro 6.0.3 (WaveMetrics, Lake Oswego, OR, USA). Statistical analysis was
performed using Prism 5.0 software (San Diego, CA, USA). In all cases “n” refers to
the number of repetitions of an experiment (each experiment being performed on
different brain slices) from single slice. Experimenters were blind to most of the
mice genotype during electrophysiological recordings and analysis. All results were
expressed as mean ± sem, and statistical significance was assessed using
Mann–Whitney test or the one sample t test when appropriate at the significance
level (p) indicated.
Spike-timing-dependent plasticity induction protocols. Electrical stimulation
was performed with a bipolar electrode (Phymep, Paris, France) placed in the layer
5 of the somatosensory cortex12,30. Electrical stimulation was monophasic at
constant current (ISO-Flex stimulator, AMPI, Jerusalem, Israel). Currents were
adjusted to evoke 50–200 pA EPSCs. Repetitive control stimuli were applied at 0.1
Hz. STDP protocols consisted in pairings of pre- and postsynaptic stimulations
(at 1 Hz) separated by a temporal interval (ΔtSTDP). Presynaptic stimulations
corresponded to cortical stimulations and the postsynaptic stimulation of an action
potential evoked by a depolarizing current step (30 ms duration) in MSNs. MSNs
were maintained all along the STDP experiments at a constant holding membrane
potential which corresponds to their initial resting membrane potential (−81.6 ±
0.4 mV, n= 61). Thus, across experiment EPSCs were measured at the same
membrane potential (voltage-clamp mode); STDP pairings (current-clamp mode)
were conducted at this same holding membrane potential. Neurons were
recorded for 10 min during baseline and for at least 50 min after STDP protocol;
long-term synaptic efficacy changes were measured from 50 min. 30 successive
EPSCs (at 0.1 Hz) were individually measured and averaged. Variation of input and
access resistances, measured every 10 s all along the experiment, beyond 20% led
to the rejection of the experiment.
STDP protocol consisting in 5–10 post-pre pairings (with a single postsynaptic
spike) were sufficient to induce potent tLTP in rat while in C57BL/6 mice 15
pairings (with 2–3 postsynaptic spikes) were necessary to trigger tLTP.
Chemicals. N-(piperidin-1-yl)-5-(4-iodophenyl)-1-(2,4-dichlorophenyl)-4-methyl-
1H-pyrazole-3-carboxamide (AM251, 3 μM, Tocris) and (S-)-5-Aminosulfonyl-N-
[(1-ethyl-2-pyrrolidinyl)methyl]-2-methoxybenzamide (sulpiride, 10 μM, Tocris)
and (2E)-N-(2,3-Dihydro-1,4-benzodioxin-6-yl)-3-[4-(1,1-dimethylethyl)phenyl]-
2-propenamide (AMG9810, 1 μM) were dissolved in ethanol and then added in the
external solution at a final concentration of ethanol of 0.01–0.1%. R(+)-7-Chloro-
8-hydroxy-3-methyl-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine hydrochloride
(SCH-23390, 4 μM, Sigma), (4aR-trans)-4,4a,5,6,7,8,8a,9-Octahydro-5-propyl-1H-
pyrazolo[3,4-g]quinoline hydrochloride (quinpirole, 10 μM, Tocris) and +N-(2,6-
Dimethylphenylcarbamoylmethyl)triethylammonium chloride (QX-314, 10 μM,
Tocris) were dissolved in water and added in the external solution. None of the
bath-applied drugs had a significant effect on basal EPSC amplitudes: AM251
(3 μM): 101 ± 5% (p= 0.8610, n= 7), co-application of SCH23390 (4 μM) and
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sulpiride (10 μM): 102 ± 3%, (p= 0.5056, n= 9) and quinpirole (10 μM): 98 ± 2%,
(p= 0.3449, n= 8).
Opto-inhibition of dopaminergic neurons. We bred C57BL/6 DAT-Cre+/− and
C57BL/6 Arch3-GFP+/+ mice (Jackson Laboratory) leading to mice that selectively
expressed Archeo-rhodopsin in DAT-expressing neurons (DAT-Cre+/−::Arch3-
GFP+/− mice); DAT-Cre−/−::Arch3-GFP+/− mice were used as a control. 585 nm
yellow-green light was delivered via field illumination using a high-power LED
source (pE excitation System, CoolLED, Andover, UK).
Double immunostaining for GFP (for Arch3 expression in dopaminergic
neurons) and TH. Brain slices (300 µm) were fixed overnight in 2%
paraformaldehyde at 4 °C. Non-specific binding was blocked by incubating the
slices for 2 h at room temperature in 10% normal goat serum (Merk-Millipore,
Molsheim, France) in 2% BSA and 1% Triton X-100 solution. Brain slices were
incubated with a pair of primary antibodies, chicken anti-GFP (1:2000, AB13970,
Abcam, Paris, France) and mouse anti-TH (1:500, MAB318, Merk-Millipore), in
0.5% Triton X-100, 1% BSA and 2.5% normal goat serum (overnight 4 °C), and
then with the secondary antibodies, goat anti-chicken Alexa (1:1000, A11039,
Life Technology-Invitrogen, Villebon-sur-Yvette, France) and goat anti-mouse
IgG1 (1:200, 1070–03, Southern Biotech-Clinisciences, Montrouge, France)
(overnight 4 °C).
Selective ablation of D2R-expressing MSNs. We bred C57BL/6 Adora2a-Cre+/−
and inducible C57BL/6 DTR+/+ (iDTR+/+) mice leading to double heterozygous:
mice that selectively expressed the DTR in D2R-MSN (Adora2a-Cre+/−::iDTR+/−,
A2A-DTR+/− mice) and Adora2a-Cre−/−::iDTR+/− (A2A-DTR−/− mice) used as
the corresponding control for electrophysiology48. A2A receptor promoter was
chosen because specifically expressed in striatum only by D2R-MSNs48. Inducible
ablation allows a high spatial resolution (achieved with stereotaxic injections of
toxin) and prevents developmental adaptations. We next bred Adora2a-Cre+/−::
iDTR+/− mice with Drd1a-GFP mice48 to ensure recording D1R-MSNs.
Adora2a-Cre+/−::iDTR+/−::Drd1a-GFP+/− mice (and their control Adora2a-
Cre−/−::iDTR+/−::Drd1a-GFP+/−). At the age of 4 weeks, 1 μl of DT (Sigma-
Aldrich) by side (diluted in PBS 0.01 M to a concentration of 100 pg/μl) was slowly
stereotaxically injected at 0.25 μl/min with a blunt needle in four sides of the dorsal
striatum with the following coordinates (with bregma as references): anterior +1.2
mm, lateral ±1.5 mm, ventral +3.6 mm; or anterior +0.5 mm, lateral ±1.8 mm,
ventral +3.6 mm. We reported an almost complete loss of striatal A2A receptor
binding from 14 days after DT injections48. Therefore, electrophysiological
recordings were performed from 15–20 days after DT injections.
In situ hybridization for enkephalin mRNA: Striatal 20 μm coronal sections were
cut from fresh-frozen brain (Adora2a-Cre+/−::iDTR+/−::Drd1a-GFP+/− mice) and
mounted on glass slides. After the hybridization for enkephalin mRNA
procedure48, sections were exposed to Kodak Biomax MR film for 1–2 week(s)
depending on the marker studied and digitalized images were generated from the
autoradiograms. For quantification of in situ hybridization and binding (ImageJ
software), an averaged optical density (OD) in different areas of interest was
measured and background level was subtracted to obtain corrected values. Two
to three sections were used for each animal to calculate the mean OD.
Selective ablation of ChAT interneurons. We bred C57BL/6 ChAT-Cre+/− and
inducible C57BL/6 DTR+/+ (iDTR+/+) mice leading to double heterozygous: mice
that selectively expressed the DTR in cholinergic interneurons (ChAT-Cre+/−::
iDTR+/−, ChAT-DTR+/− mice) and ChAT-Cre−/−::iDTR+/− (ChAT-DTR−/−
mice) used as the corresponding control for patch-clamp experiments. The ablation
is performed in the same condition than D2R-MSNs. 1 μl of DT (Sigma) by side
(diluted in PBS 0.01M to a concentration of 100 pg/μl) was stereotaxically injected
at 0.25 μl/min with a blunt needle in four sides of the dorsal striatum with the
following coordinates: anterior +1.2 mm, lateral ±1.5 mm, ventral +3.6 mm; or
anterior +0.5 mm, lateral ±1.8 mm, ventral +3.6 mm. An almost complete loss
of ChAT immunostaining in the striatum from 14 days after DT injections was
observed and recordings were performed from 15–20 days after DT injections.
ChAT immunostaining: ChAT-Cre+/−::iDTR+/− mice were anesthetized and
perfused transcardially with 0.01 M PBS, followed by 4% paraformaldehyde for
tissue fixation. Brains were dissected, dehydrated in 20–30% sucrose solutions and
frozen. Coronal free-floating sections of 30 μm thickness were cut through the
striatum with a freezing microtome (Leica). Sections were treated with 0.3% H2O2
in PBS (pH 7.4) 0.1% Triton X-100 for 45 min and non-specific antibody binding
was blocked with normal horse serum in PBS (pH 7.4) 0.1%Triton X-100 for
60 min. Sections were incubated 48 h at 4 °C with the rabbit primary antibody:
anti-ChAT (1/1000) (Chemicon) and then with donkey anti-rabbit biotinylated
antibody (1/200, Jackson ImmunoResearch) and visualized with the ABC
diaminobenzidine reaction.
D2R cKO in D2R-MSN, cholinergic, and dopaminergic neurons. cKO mice were
generated by crossing homologous Drd2LoxP/LoxP with heterologous specific Cre
+/− driver mice and the resulting double heterologous Cre−/+::Drd2Wt//LoxP are
crossed with heterologous Drd2Wt//LoxP. This crossing gives the cKO Cre+/−::
Drd2LoxP/LoxP, the Cre driver control Cre+/−::Drd2Wt/Wt and the floxed gene
control Cre−/−::Drd2LoxP/LoxP. The Cre-mediated deletion of Drd2 in D2R-MSNs,
striatal cholinergic interneurons, or dopaminergic neurons was obtained using
mice expressing Cre-recombinase under the control of the Adora2a promoter
(Adora2a-Cre mice47), ChAT promoter (ChAT-Cre; JAX SN6410), and Slc6a3
promoter (DAT-Cre mice), respectively.
Selective D2R cKO in neocortical pyramidal cells of layer 5. We stereotaxically
injected, in somatosensory cortex layer 5, AAV-cre-GFP (AAV1.CMV.HI.eGFP-
Cre.WPRE.SV40, UPENN Core) in C57BL/6 D2RLoxP/LoxP mice leading to selective
D2R-KO mice in corticostriatal cells; C57BL/6 D2RLoxP/LoxP mice injected with
AAV-GFP (AAV1.CMV.PI.eGFP.WPRE.bGH, UPENN Core) were used as the
corresponding control. AAV-GFP and AAV-cre-GFP were stereotaxically injected
at 0.1 μl/min with a blunt needle in four (bilaterally) sides of the somatosensory
cortex with the following coordinates: anterior + 1.2 and +0.1 mm, lateral ±3.5 and
±3.8 mm, ventral −3.2 mm. Electrophysiological recordings were performed from
15–30 days after viral injection.
D2R immunostaining. D2RLoxP/LoxP mice were anesthetized and perfused trans-
cardially with 0.01M PBS, followed by 4% paraformaldehyde for tissue fixation.
Brains were dissected, dehydrated in 20–30% sucrose solutions and frozen. Coronal
sections of 16 μm thickness were cut through the striatum with a freezing micro-
tome (Leica). Non-specific antibody binding was blocked with normal horse serum
in PBS (pH 7.4) 0.1%Triton X-100 for 60 min. Sections were incubated 24 h at 4 °C
with the rabbit primary antibody: anti-D2R (1/1000) (Frontier Science) and then
with donkey anti-rabbit Alexa594 (1/200, Jackson ImmunoResearch).
SNc or MFB 6-OHDA-lesioned rats and L-DOPA treatment. 6-OHDA-lesioned
animals: Sprague–Dawley rats weighing 125–150 g (Charles River Laboratories,
L’Arbresle, France) were anesthetized with sodium pentobarbital (30 mg/kg i.p.;
Ceva Sante Animale, Libourne, France) supplemented by injections of ketamine
(27.5 mg/kg, im; Imalgène, Merial, Lyon, France). Thirty minutes before the
injection of 6-OHDA (or vehicle in sham-operated animals), all animals received a
bolus of desipramine (25 mg/kg, i.p.; Sigma-Aldrich) to prevent neurotoxin-
induced damage of noradrenergic neurons. Animals were fixed in a stereotaxic
frame (Kopf Instruments, Tujunga, CA, USA). Body temperature was maintained
at 36.5 °C with a homeothermic blanket (Harvard Apparatus, Kent, UK). A small
craniotomy was made unilaterally (left side) over the SNc or MFB and the
overlying dura mater was removed. For the Parkinson’s disease model and for the
removal of the nigrostriatal dopaminergic cells, an unilateral 6-OHDA lesion of
the SNc and MFB were performed, respectively. A single stereotaxic injection of
6-OHDA (or of vehicle in the sham-operated animals) was delivered into the SNc
on the left side (stereotaxic coordinates anteriority from the interaural line (A): 3.7
mm, laterality from the midline (L): 2.1 mm, depth from the cortical surface (H):
−7.55 mm). Concerning the MFB lesion, 6-OHDA was injected into the left MFB;
stereotaxic coordinates anteriority from the bregma (A): 4.5 mm, laterality from the
midline (L): 1.2 mm, depth from the cortical surface (H): −7.9 mm. 6-OHDA
(hydrochloride salt; Sigma) was dissolved immediately prior use in ice-cold
0.9% w/v NaCl solution containing 0.01% w/v ascorbic acid to a final concentration
of 2.5 mg/ml. 4.0 μl of this 6-OHDA solution (or vehicle) was injected at a rate of
16 μl/h via a steel cannula (0.25 mm outside diameter) attached to a 10 μl Hamilton
microsyringe (Cole-Parmer, London, UK) controlled by an electrical pump
(KDS100; KD Scientific, Holliston, MA). After surgery, animals received an
intramuscular injection of gentamicin to prevent bacterial infection (3 mg/kg,
im; Gentalline, Schering-Plough, Levallois-Perret, France).
Chronic L-DOPA treatment: Two weeks after 6-OHDA injection, rats were
splitted into two groups which received i.p. injection twice-daily for 10 days of
either L-DOPA (10 mg/kg) with benzerazide (7.5 mg/kg) or saline. The sham-
operated animals were also subjected to L-DOPA or saline injections with the same
schedule. Animals received the last injection of L-DOPA or saline 30–60 min
before being sacrified for ex vivo experiments.
TH immunostaining: The severity of the 6-OHDA lesions was quantified by
striatal TH immunostaining. Brain slices were incubated in 0.1% H2O2 and 10%
methanol in PBS (15 min) and then in a 1/500 dilution of mouse anti-TH
monoclonal antibody (MAB318; Merk-Millipore) overnight at 4 °C. Biotin-goat
anti-mouse secondary antibody (Life Technology-Invitrogen, Villebon-sur-Yvette,
France) was incubated at a dilution of 1/500 for 2.4 h at room temperature and
visualized using with avidin–biotin complex (ABC Elite standard, PK-4000, Vector
Laboratories, Burlingame, CA, USA) and DAB detection kit (Vector Laboratories).
Mathematical model. We used the mathematical model of corticostriatal synaptic
plasticity13 with two additional parameters related to presynaptic plasticity (see
below). This model implements a single dendritic spine and a soma as a single
isopotential electrical compartment. Electrical activation is coupled to a detailed
description of the postsynaptic signaling pathways from calcium currents to the
activation of CaMKIIα and production of eCBs. Ordinary differential equations
based on classical mass-action law formalisms are then used to express the
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corresponding reaction kinetics. Plasticity outcome is determined byWtotal that has
pre-and postsynaptic components and was computed as Wtotal=Wpre⋅Wpost.
We modeled the glutamate concentration in the synaptic cleft, G(t), as a train of




exp  t  tprei
τG
 
Θ t  tprei
 
ð1Þ
where Gmax is the peak glutamate concentrations and τG is the glutamate clearance
rate. On the postsynaptic side, action currents resulting from postsynaptic
stimulations were modeled according to:
Iaction tð Þ ¼ DCmax
X
i





Θðt  δ  tposti Þexp




where the rectangle function R(t, a, l) = Θ(t− a)−Θ(t− a− l), DCmax and DCdur
are the amplitude and duration of step-current injected in the postsynaptic soma,
APmax is the amplitude of the action current producing the back-propagating
action potential (bAP); τbAP is the timescale for bAP decay and δ accounts for the
time elapsed between the onset of the postsynaptic step current and the action
potential it triggers (~3 ms in MSNs). We modeled the electrical response to these
stimulations in a postsynaptic element considered as a single isopotential
compartment with AMPAR, NMDAR, VSCC, and TRPV1 conductances:
Cm
dV
dt ¼ gLðV  VLÞ  IAMPARðV ;GðtÞÞ  INMDARðV;GðtÞÞ
IVSCCðVÞ  ITRPV1ðV ;AEAÞ  IactionðtÞ
ð3Þ
where V is membrane potential; gL and VL are leak conductance and reversal
potential, respectively, and AEA stands for anandamide. For a detailed exposition
of the models used for those currents, see refs. 12,13.








where the fluxes JIP3R, JSERCA, Jleak from and to the ER in the Calcium-Induced
Calcium Release (CICR) system were taken from the model of De Pitta ̀ et al.73
(see also ref. 12) and JNMDAR, JVSCC, and JTRPV1 are the calcium fluxes from the
plasma membrane channels (Eq. (3)). Cb is the basal cytosolic calcium level
resulting from equilibration with calcium diffusion out of the cell and τCb is the
corresponding timescale. TC(C) is a time scaling factor accounting for the presence
of endogenous calcium buffers. See Cui et al.12 for details.
Wpost was based on the activation by calcium of calmodulin and CaMKII and
the regulation of this system by PKA, calcineurin and protein phosphatase 1 (PP1).
The model of Cui et al.12 for this subsection is based on the biophysical model
proposed in Graupner and Brunel74, that expresses the calcium-dependent kinetics
of the protein complexes and enzymes along this pathway, including the calcium-
dependent kinetics of CaMKII*, the activated form of CaMKII, that was assumed to
set postsynaptic plasticity according to:




where CaMKIImax is the maximal concentration of activate (phosphorylated)
CaMKII.
Our model also accounts for the biochemical pathways leading to the
production of the endocannabinoids 2-arachidonoylglycerol (2-AG) and AEA, and
their subsequent CB1R activation. We modeled CB1R activation by 2-AG and AEA









¼ εCB1RdCB1R þ γCB1RxCB1R ð7Þ
where eCB= 2-AG+ 0.10 AEA accounts for the act that AEA is a partial agonist of
CB1R.
In the original model13, CB1R activation controls presynaptic plasticity via the
CB1R-triggered Gi/o-GPCR pathway. Here, we add the assumption that the effects
of D2R and CB1R on Wpre are cumulative. We account here for the resulting
synergistic effects by combining both effects linearly in the variable yG that controls
Wpre:
yG ¼ kCB1R  xCB1R þ γD2R  DAþ γother ð8Þ
where xCB1R is the fraction of activated (non-desensitized) CB1R, kCB1R quantifies
the effect of CB1R activation, DA is the concentration of (tonic) dopamine, γD2R
quantifies the effect of D2R activation and γother summarizes the effects of other Gi/
o-GPCR pathways (beyond CB1R and D2R). Note that yG was actually referred to as
yCB1R in ref. 13 whereas the term γD2R⋅DA+ γother was lumped in a constant D1.
Finally, we assume that yG controls Wpre, which we express in the model via two
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ΩðyGÞ ¼
1þ ALTP ; if θstartLTD<yG<θstopLTD;













thresholds. Here, Ω sets the steady-state presynaptic weight, while 1=τWpre sets the
rate at which this steady-state is approached. Ω decreases (LTD) when yG is in
between the two threshold values, θstartLTD and θ
stop
LTD whereas Ω rises (LTP) if yG
becomes larger than θstartLTP (dashed line in Fig. 8c). Therefore, Wpre depends on yG
and yG indirectly depends on cytoplasmic calcium, thus on spike timing. As a
result, Wpre depends on spike timing in the model.
In the present study, we used kCB1R= 2400; γD2R= 0.84, DA= 0.01 µM, γother
= 12.6⋅10−3; ALTD= 1.82, ALTP= 24, θ
stop
LTD ¼ 0:053 and θstartLTP ¼ 0:085. For all other
parameters, we used the same values as in ref. 13.
Data availability
All relevant data are available from the authors. The mathematical model can be
downloaded from https://senselab.med.yale.edu/modeldb/, accession #187605.
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